Brian Meshkin Nominated for the 2016 Orange County Business Journal Excellence in Entrepreneurship Award

Share Article

Proove Biosciences CEO Nominated for Another Entrepreneurship

Proove Biosciences Inc., the commercial and research leader in personalized pain medicine, is pleased to announce the nomination of Brian Meshkin for the Excellence in Entrepreneurship Award by the Orange County Business Journal—a distinction that recognizes leaders who embody the American entrepreneurial spirit. “I am humbled to be among the many forward-thinking entrepreneurs who are reshaping our respective industries here in California,” said Brian Meshkin, CEO at Proove Biosciences. The 15th annual Excellence in Entrepreneurship Awards program is hosted by the Orange County Business Journal—the county’s most prominent business publication. The winners will be announced at a special reception on Thursday, March 10, 2016.

As technology continues the change, Proove is at the forefront of delivering information that leads to better health outcomes. “We are on a mission to change lives—and that starts with using technology in a manner that gives doctors the proof they need to improve healthcare decisions,” explained Meshkin. Proove Biosciences uses a patented technology platform to assess genetic variations along with other health data to objectively assess patient pain perception and help predict which patients are at risk for the misuse of opioids – the leading cause of injury death in America and the leading cause of death among teenagers. “We are changing the paradigm in medicine by using precision medicine and digital health technologies — and we are just getting started.”

About Proove Biosciences
Our mission is to change the future of medicine. Proove represents the proof to improve healthcare decisions. We seek to realize a future when clinicians look back and wonder how they could have ever prescribed medications without knowing how a patient would respond. Physicians use Proove Biosciences testing to improve outcomes—both safety and efficacy of medical treatment. From a simple cheek swab collected in the office, Proove performs proprietary genetic tests in its CLIA-certified laboratory to identify patients at risk for misuse of prescription pain medications and evaluate their metabolism of medications. For more information, please visit or call toll free 855-PROOVE-BIO (855-776-6832).

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Genevieve McCormick
Follow >
Proove Biosciences, Inc.
since: 02/2012
Like >